Musculoskeletal and Obstetric Management Study (MOMS)

May 19, 2009 updated by: Logan College of Chiropractic

Musculoskeletal and Obstetric Management Study (MOMS)

The investigators propose such a trial to compare a Musculoskeletal and Obstetric Management (MOM) program to standard obstetric care alone for lower back pain/pelvic pain (LBP/PP) during and after pregnancy.

Study Overview

Detailed Description

Initially patients will have a Baseline Musculoskeletal Exam (BME) at 24-28 weeks pregnancy at which point self reported tests/questionnaires will be administered as well as functional testing (see below "procedures for research") performed. At this point patients will be randomized into either Standard Obstetric Management or Musculoskeletal and Obstetric Care (MOMS) groups:

Standard Obstetric Management : All patients (both groups) will be seen for standard obstetric care typically once every month. Complicated cases may need to be seen more frequently. There is no standard obstetric care approach to LBP/PP in pregnancy, thus, patients in the standard obstetric care group will receive limited, although realistic interventions for LBP/PP. In addition, patients will attend one-on-one educational sessions on pre-natal care. The women in this group will have a minimum of 4 pre-natal care sessions. These visits will be timed to match the additional time and care given to the MOM group. The timed sessions will be compared with the MOMS group at monthly intervals to maintain treatment attention equality. Patients will have a complete medical assessment including history and physical examination administered by their obstetrical provider. As part of their intervention for LBP/PP, evaluation of lifestyle and work activities may be taken into consideration. Modification of lifestyle may be recommended including, rest and general aerobic exercise. Short-lived heat treatment (i.e. heating pad for no more than 10 minutes) is another possibility. Use of analgesia may be prescribed, including acetaminophen and NSAID preparations, or narcotics if deemed necessary by the provider. Narcotic use and centrally acting muscle relaxants are typically not encouraged, but at times maybe necessary to help control pain. For pain that is debilitating and worsening, consultation with orthopedic or neurological services may be considered.

Musculoskeletal and Obstetric Management (MOM): In addition to their standard obstetric visits, patients in this group will see the MOM team every one to two weeks depending on severity of symptoms. We have found through treating pregnancy-related pain that visits every one to two weeks is sufficient as the majority of the cases are mild to moderate presentations of non-inflammatory pain. A standard history will be taken and the patient will be assessed for musculoskeletal conditions to identify signs of serious illness, neurological deficit and/or orthopedic instability. If any of these conditions are evident, the patient will be immediately referred for specialist consultation. The patients in this MOM group will be treated with biobehavioral management, manual therapy and spinal stabilization exercise as described in detail below. The obstetric physician and chiropractic physician will have coordinated schedules at each clinic. For pain that is debilitating and worsening, consultation with orthopedic or neurological services will be considered.

Patients will be assessed at 33 weeks gestation and 3 months post-partum and research end-points collected. Please see next cell for detailed description of these functional and endurance tests as well as self reported test.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • St Louis, Missouri, United States, 63110
        • Center for Advanced Medicine
      • St. Louis, Missouri, United States, 63110
        • Barnes-Jewish Hospital
      • St. Louis, Missouri, United States, 63131
        • Missouri Baptist Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 45 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female Patients 15-45 years of age
  • Pregnant - 24-28 weeks gestation
  • LBP and/or PP

Exclusion Criteria:

  • History of fracture, neoplasm, previous surgery of lumbar spine, pelvis, hip or femur
  • Acute inflammatory or infectious disease
  • Chronic pain prior to pregnancy (pain persisting for > 8 weeks prior to pregnancy)
  • Mental health disorder requiring medication/treatment
  • Back pain from visceral diseases
  • Peripheral vascular disease and/or cardiac disease requiring medical treatment
  • Severe disabling health problems
  • Substance abuse
  • Ongoing treatment for back pain by other health care providers
  • Pending or current litigation
  • Multiple birth pregnancies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MOMS
Receives manual therapy, stabilization exercise and patient education
Receives manual therapy, stabilization exercise and patient education
Active Comparator: STOB
Receive standard obstetrical care
Receive standard obstetrical care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Quebec Task Force Disability Scale Questionnaire (QDQ)
Time Frame: Baseline, 33 weeks of gestation and 3 months postpartum
Baseline, 33 weeks of gestation and 3 months postpartum

Secondary Outcome Measures

Outcome Measure
Time Frame
Numerical Rating Scale (NRS)
Time Frame: Baseline, 33 weeks of gestation and 3 months postpartum
Baseline, 33 weeks of gestation and 3 months postpartum
Personal Pain History (PPH)
Time Frame: Baseline, 33 weeks of gestation and 3 months postpartum
Baseline, 33 weeks of gestation and 3 months postpartum
Straight Leg Raise (SLR)
Time Frame: Baseline, 33 weeks of gestation and 3 months postpartum
Baseline, 33 weeks of gestation and 3 months postpartum
Active Straight Leg Raise (ASLR)
Time Frame: Baseline, 33 weeks of gestation and 3 months postpartum
Baseline, 33 weeks of gestation and 3 months postpartum
Long Dorsal Ligament Test (LDLT)
Time Frame: Baseline, 33 weeks of gestation and 3 months postpartum
Baseline, 33 weeks of gestation and 3 months postpartum
Posterior Pelvic Pain in Pregnancy Test (P4)
Time Frame: Baseline, 33 weeks of gestation and 3 months postpartum
Baseline, 33 weeks of gestation and 3 months postpartum
Extensor Endurance Test (EET)
Time Frame: 3 months postpartum
3 months postpartum
Flexor Endurance Test (FET)
Time Frame: 3 months postpartum
3 months postpartum
Side Bridge (SB)
Time Frame: 3 months postpartum
3 months postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2006

Primary Completion (Anticipated)

June 1, 2009

Study Completion (Anticipated)

June 1, 2009

Study Registration Dates

First Submitted

May 18, 2009

First Submitted That Met QC Criteria

May 19, 2009

First Posted (Estimate)

May 20, 2009

Study Record Updates

Last Update Posted (Estimate)

May 20, 2009

Last Update Submitted That Met QC Criteria

May 19, 2009

Last Verified

May 1, 2009

More Information

Terms related to this study

Other Study ID Numbers

  • 06-0998
  • 417 (DRD)
  • 1 R18HP07640-01-00 (Award #)
  • R18HP07640 (Grant #)
  • RD1012060046 (Logan IRB #)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Back Pain

Clinical Trials on Manual Therapy

Subscribe